181 related articles for article (PubMed ID: 35606395)
1. A new model based inflammatory index and tumor burden score (TBS) to predict the recurrence of hepatocellular carcinoma (HCC) after liver resection.
Wang J; Chen Z; Wang L; Feng S; Qiu Q; Chen D; Li N; Xiao Y
Sci Rep; 2022 May; 12(1):8670. PubMed ID: 35606395
[TBL] [Abstract][Full Text] [Related]
2. Systemic Immune-Inflammation Index (SII) is Useful to Predict Survival Outcomes in Patients After Liver Transplantation for Hepatocellular Carcinoma within Hangzhou Criteria.
Fu H; Zheng J; Cai J; Zeng K; Yao J; Chen L; Li H; Zhang J; Zhang Y; Zhao H; Yang Y
Cell Physiol Biochem; 2018; 47(1):293-301. PubMed ID: 29768257
[TBL] [Abstract][Full Text] [Related]
3. [Relationship between preoperative inflammatory indexes and prognosis of patients with rectal cancer and establishment of prognostic nomogram prediction model].
Zhang L; Shi FY; Qin Q; Liu GX; Zhang HW; Yan J; Tan M; Wang LZ; Xue D; Hu CH; Zhang Z; She JJ
Zhonghua Zhong Liu Za Zhi; 2022 May; 44(5):402-409. PubMed ID: 35615796
[No Abstract] [Full Text] [Related]
4. [The prognostic value of preoperative peripheral blood inflammatory biomarkers for intrahepatic cholangiocarcinoma after radical resection].
Li Q; Zhang R; Fu JL; Zhang J; Su JB; Jin ZC; Chen C; Zhang D; Geng ZM
Zhonghua Zhong Liu Za Zhi; 2022 Nov; 44(11):1194-1201. PubMed ID: 36380668
[No Abstract] [Full Text] [Related]
5. The Prognostic Role of a Combined Fibrinogen and Neutrophil-to-Lymphocyte Ratio Score in Patients with Resectable Hepatocellular Carcinoma: A Retrospective Study.
Kong W; Xu H; Cheng J; Fang Z; Wang H; Zhang J; Wang X; Dai T; Gao Y
Med Sci Monit; 2020 Jan; 26():e918824. PubMed ID: 31929496
[TBL] [Abstract][Full Text] [Related]
6. [Correlation between postoperative neutrophil to lymphocyte ratio and recurrence and prognosis of hepatocellular carcinoma after radical liver resection].
Wu XL; Bi XY; Li ZY; Zhao H; Zhao JJ; Zhou JG; Huang Z; Zhang YF; Cai JQ
Zhonghua Zhong Liu Za Zhi; 2018 May; 40(5):365-371. PubMed ID: 29860764
[No Abstract] [Full Text] [Related]
7. Overall Tumor Burden Dictates Outcomes for Patients Undergoing Resection of Multinodular Hepatocellular Carcinoma Beyond the Milan Criteria.
Tsilimigras DI; Mehta R; Paredes AZ; Moris D; Sahara K; Bagante F; Ratti F; Marques HP; Silva S; Soubrane O; Lam V; Poultsides GA; Popescu I; Grigorie R; Alexandrescu S; Martel G; Workneh A; Guglielmi A; Hugh T; Aldrighetti L; Endo I; Spolverato G; Umberto C; Pawlik TM
Ann Surg; 2020 Oct; 272(4):574-581. PubMed ID: 32932309
[TBL] [Abstract][Full Text] [Related]
8. Predictive value of preoperative inflammatory indexes for postoperative early recurrence of hepatitis B-related hepatocellular carcinoma.
Wenpei G; Yuan L; Liangbo L; Jingjun M; Bo W; Zhiqiang N; Yijie N; Lixin L
Front Oncol; 2023; 13():1142168. PubMed ID: 37519805
[TBL] [Abstract][Full Text] [Related]
9. Inflammatory indexes in preoperative blood routine to predict early recurrence of hepatocellular carcinoma after curative hepatectomy.
Wu Y; Tu C; Shao C
BMC Surg; 2021 Apr; 21(1):178. PubMed ID: 33794850
[TBL] [Abstract][Full Text] [Related]
10. Preoperative fibrinogen-to-albumin ratio predicts the prognosis of patients with hepatocellular carcinoma subjected to hepatectomy.
Mai RY; Bai T; Luo XL; Wu GB
BMC Gastroenterol; 2022 May; 22(1):261. PubMed ID: 35606690
[TBL] [Abstract][Full Text] [Related]
11. PIVKA-II combined with tumor burden score to predict long-term outcomes of AFP-negative hepatocellular carcinoma patients after liver resection.
Qiu ZC; Wu YW; Qi WL; Li C
Cancer Med; 2023 Dec; 13(1):. PubMed ID: 38130028
[TBL] [Abstract][Full Text] [Related]
12. Preoperative inflammatory markers as prognostic predictors after hepatocellular carcinoma resection: data from a western referral center.
Silva JPM; Coelho FF; Cassenote AJF; Jeismann VB; Fonseca GM; Kruger JAP; de Meira Júnior JD; Nahas SC; Herman P
BMC Surg; 2022 Sep; 22(1):329. PubMed ID: 36056350
[TBL] [Abstract][Full Text] [Related]
13. Inflammation scores predict the survival of patients with hepatocellular carcinoma who were treated with transarterial chemoembolization and recombinant human type-5 adenovirus H101.
He CB; Lin XJ
PLoS One; 2017; 12(3):e0174769. PubMed ID: 28355305
[TBL] [Abstract][Full Text] [Related]
14. Comparison of the prognostic value of inflammation-based scores in early recurrent hepatocellular carcinoma after hepatectomy.
Wang C; He W; Yuan Y; Zhang Y; Li K; Zou R; Liao Y; Liu W; Yang Z; Zuo D; Qiu J; Zheng Y; Li B; Yuan Y
Liver Int; 2020 Jan; 40(1):229-239. PubMed ID: 31652394
[TBL] [Abstract][Full Text] [Related]
15. Prognostic significance of preoperative aspartate aminotransferase to neutrophil ratio index in patients with hepatocellular carcinoma after hepatic resection.
Ji F; Fu S; Guo Z; Pang H; Chen D; Wang X; Ju W; Wang D; He X; Hua Y; Peng B
Oncotarget; 2016 Nov; 7(44):72276-72289. PubMed ID: 27472390
[TBL] [Abstract][Full Text] [Related]
16. The Prognostic Value of Inflammation Factors in Hepatocellular Carcinoma Patients with Hepatic Artery Interventional Treatments: A Retrospective Study.
Guo L; Ren H; Pu L; Zhu X; Liu Y; Ma X
Cancer Manag Res; 2020; 12():7173-7188. PubMed ID: 33061563
[TBL] [Abstract][Full Text] [Related]
17. Radiographic tumor burden score is useful for stratifying the overall survival of hepatocellular carcinoma patients undergoing resection at different Barcelona Clinic Liver Cancer stages.
Li WF; Liu YW; Wang CC; Yong CC; Lin CC; Yen YH
Langenbecks Arch Surg; 2023 May; 408(1):169. PubMed ID: 37121930
[TBL] [Abstract][Full Text] [Related]
18. The Clinicopathological and Prognostic Value of NLR, PLR and MLR in Non-Muscular Invasive Bladder Cancer.
Chen H; Wu X; Wen Z; Zhu Y; Liao L; Yang J
Arch Esp Urol; 2022 Jun; 75(5):467-471. PubMed ID: 35983820
[TBL] [Abstract][Full Text] [Related]
19. Hepatocellular carcinoma tumour burden score to stratify prognosis after resection.
Tsilimigras DI; Moris D; Hyer JM; Bagante F; Sahara K; Moro A; Paredes AZ; Mehta R; Ratti F; Marques HP; Silva S; Soubrane O; Lam V; Poultsides GA; Popescu I; Alexandrescu S; Martel G; Workneh A; Guglielmi A; Hugh T; Aldrighetti L; Endo I; Sasaki K; Rodarte AI; Aucejo FN; Pawlik TM
Br J Surg; 2020 Jun; 107(7):854-864. PubMed ID: 32057105
[TBL] [Abstract][Full Text] [Related]
20. Recurrence beyond the Milan criteria after curative-intent resection of hepatocellular carcinoma: A novel tumor-burden based prediction model.
Tsilimigras DI; Mehta R; Guglielmi A; Ratti F; Marques HP; Soubrane O; Lam V; Poultsides GA; Popescu I; Alexandrescu S; Martel G; Hugh T; Aldrighetti L; Endo I; Pawlik TM
J Surg Oncol; 2020 Oct; 122(5):955-963. PubMed ID: 32602143
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
